Treatment of Acute COPD Exacerbation in the Emergency Department
Initiate treatment immediately with short-acting bronchodilators (both beta-agonists and anticholinergics together), systemic corticosteroids (40 mg prednisone daily for 5 days), controlled oxygen therapy targeting SpO2 90-93%, and antibiotics if there is increased sputum purulence plus either increased dyspnea or sputum volume. 1, 2
Initial Assessment and Oxygen Therapy
- Measure arterial blood gases within 60 minutes of starting oxygen therapy to assess for hypercapnia and respiratory acidosis, as pH below 7.26 predicts poor outcomes 3
- Target oxygen saturation of 90-93% using controlled delivery (Venturi mask at ≤28% FiO2 or nasal cannula at 1-2 L/min initially) to avoid CO2 retention 3, 2
- Repeat blood gas measurements if the patient is initially acidotic or hypercapnic, or if clinical status deteriorates 3
Bronchodilator Therapy
Administer both short-acting beta-agonists AND anticholinergics together from the start for severe exacerbations rather than using either agent alone 3, 1, 2
- Nebulized salbutamol 2.5-5 mg (or terbutaline 5-10 mg) PLUS ipratropium bromide 0.25-0.5 mg should be given on arrival and repeated every 4-6 hours 3, 1
- Either metered-dose inhalers with spacers or nebulizers are equally effective, though nebulizers are easier for sicker patients who cannot coordinate 20+ inhalations 1, 2
- Drive nebulizers with compressed air (not oxygen) if PaCO2 is elevated or respiratory acidosis is present, while continuing supplemental oxygen via nasal prongs at 1-2 L/min during nebulization 3
- Continue nebulized bronchodilators for 24-48 hours until clinical improvement, then switch to metered-dose inhalers 3
Critical Caveat on Theophylline
Do NOT use intravenous methylxanthines (aminophylline/theophylline) due to increased side effects without proven benefit 1, 2, 4
Systemic Corticosteroids
Give oral prednisolone 30-40 mg daily for exactly 5 days starting immediately 3, 1, 2
- Oral administration is equally effective to intravenous and should be the default route unless the patient cannot tolerate oral intake 1, 2
- If oral route is not possible, use hydrocortisone 100 mg IV 3
- Do NOT extend treatment beyond 5-7 days as corticosteroids reduce recurrent exacerbations within 30 days but provide no benefit beyond this window 1
- Corticosteroids may be less effective in patients with lower blood eosinophil levels 1, 2
- Discontinue after the acute episode unless there is a definite indication for long-term treatment 3
Antibiotic Therapy
Give antibiotics when there is increased sputum purulence PLUS either increased dyspnea OR increased sputum volume 1, 2
- Antibiotics reduce short-term mortality by 77%, treatment failure by 53%, and sputum purulence by 44% 1, 2
- Recommended duration is 5-7 days 1, 2
- First-line choices: amoxicillin or tetracycline (unless previously used with poor response) 3
- Second-line alternatives for severe exacerbations or lack of response: broad-spectrum cephalosporin, newer macrolides (e.g., azithromycin), or amoxicillin/clavulanic acid 3, 5
- Base antibiotic selection on local bacterial resistance patterns; common pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 3
Respiratory Support for Severe Cases
Initiate noninvasive ventilation (NIV) immediately as first-line therapy for patients with acute hypercapnic respiratory failure and respiratory acidosis 1, 2
- NIV improves gas exchange, reduces work of breathing, decreases need for intubation, shortens hospitalization, and improves survival 1, 2
- Consider ICU admission for very severe, life-threatening episodes 3
Additional Considerations
- Diuretics are indicated only if there is peripheral edema and elevated jugular venous pressure 3
- Prophylactic subcutaneous heparin should be given for patients with acute-on-chronic respiratory failure 3
- Chest physiotherapy is NOT recommended in acute COPD exacerbations 3
Discharge Planning
- Initiate maintenance therapy with long-acting bronchodilators before hospital discharge 1, 2
- Schedule pulmonary rehabilitation within 3 weeks after discharge to reduce readmissions and improve quality of life (do NOT start during hospitalization as this increases mortality) 1
- Provide smoking cessation counseling 1
- At 8 weeks post-exacerbation, 20% of patients have not recovered to baseline, emphasizing the need for close follow-up 1, 2
Common Pitfalls to Avoid
- Do not use ipratropium as monotherapy—the FDA label warns it has not been adequately studied as a single agent for acute COPD exacerbations 6
- Do not delay blood gas measurement—waiting can miss critical hypercapnia or acidosis 3
- Do not power nebulizers with oxygen in hypercapnic patients—use compressed air 3
- Do not extend corticosteroid treatment beyond 5-7 days without specific indication 3, 1